Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye

NCT: NCT07806240 · COMPLETED

NCT IDNCT07806240
StatusCOMPLETED
Start Date2025-04-08
Completion2026-02-28
SponsorZhejiang Raytone Bioscience Co.,Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to test if a new dissolvable tacrolimus plug placed in the tear duct is safe and to see how well it works for adults with moderate to severe dry eye. The main questions it aims to answer are: Is the dissolvable tacrolimus plug safe for the eyes? How well does the plug work to improve dry eye? Participants will be divided into three groups: Two groups will receive the dissolvable tacrolimus plug inserted into their tear duct (in two slightly different sizes). One comparison group will receive an already approved dissolvable plug (Dissolvable VisiPlug). All participants will use a standard lubricating eye drop four times a day in both eyes. All participants will attend follow-up visits for 24 weeks so doctors can check their eye health and any side effects.

Frequently Asked Questions

What is Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye?

Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye is a clinical trial registered under NCT07806240. Current status: COMPLETED.

What is the status of NCT07806240?

The current status of NCT07806240 (Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye) is: COMPLETED.

When did Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye start?

Safety and Efficacy Study of Absorbable Tacrolimus Lacrimal Canalicular Plug for Dry Eye started on 2025-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.